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Abstract
Background Phenylketonuria (PKU) causes irreversible cen-
tral nervous system damage unless a phenylalanine (PHE)
restricted diet with amino acid supplementation is maintained.
To prevent growth retardation, a protein/amino acid intake
beyond the recommended dietary protein allowance is
mandatory. However, data regarding disease and/or diet related
changes in body composition are inconclusive and retarded
growth and/or adiposity is still reported. The BodPod whole
body air-displacement plethysmography method is a fast, safe
and accurate technique to measure body composition.
Aim To gain more insight into the body composition of
children with PKU.
Methods Patients diagnosedwith PKU born between 1991 and
2001 were included. Patients were identified by neonatal
screening and treated in our centre. Body composition was
measured using the BodPod system (Life Measurement
Incorporation©). Blood PHE values determined every 1–
3months in the year preceding BodPod analysis were collected.
Patients were matched for gender and age with data of healthy
control subjects. Independent samples t tests, Mann–Whitney
and linear regression were used for statistical analysis.
Results The mean body fat percentage in patients with PKU
(n=20) was significantly higher compared to healthy
controls (n=20) (25.2% vs 18.4%; p=0.002), especially in
girls above 11 years of age (30.1% vs 21.5%; p=0.027).
Body fat percentage increased with rising body weight in
patients with PKU only (R=0.693, p=0.001), but did not
correlate with mean blood PHE level (R=0.079, p=0.740).
Conclusion Our data show a higher body fat percentage in
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Introduction
Phenylketonuria (PKU, OMIM 261600) is an autosomal
recessive inborn error of phenylalanine (PHE) metabolism,
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caused by a deficient function of phenylalanine hydroxy-
lase (EC 1.14.16.1), which converts PHE to tyrosine
(Walter et al 2006). Untreated, accumulation of PHE occurs
and patients develop irreversible central nervous system
damage. Treatment consists of a dietary restriction of PHE
(Walter et al 2006). In addition, some patients may profit
from tetrahydrobiopterin (BH4) supplementation (Blau and
Erlandsen 2004). A normal intellectual development is
expected when adequate treatment is started early in life
and continued during life (DeRoche and Welsh 2008;
Walter et al 2006).
The PKU diet comprises a restriction of natural protein
and supplementation of essential amino acids with a PHE
free amino acid mixture (Walter et al 2006). In the last
century, patients on this diet often developed growth
retardation (Allen et al 1996; Verkerk et al 1994).
Therefore, nowadays, a total protein/amino acid intake
exceeding the recommended dietary allowance (RDA) is
advised (Acosta et al 2003). However, data regarding
disease and/or diet related changes in growth and body
composition are inconclusive and retarded growth is still
being reported, mainly during the first years of life (Arnold
et al 2002; Dobbelaere et al 2003). In addition, McBurnie et
al (1991) showed higher body weights in prepubertal (age
2–10 years) children with PKU when compared to healthy
control subjects, starting after 3 years of age and being
positively related to serum PHE level. This effect was
especially seen in girls. Furthermore, Walter et al (2002)
reported blood PHE levels near or above the recommended
upper limits, mainly among adolescents and young adults
(age ≥10 years) compared to younger children (age<
10 years). This finding confirms a relatively low diet
adherence in the former age group (Walter et al 2002).
The BodPod whole body air-displacement plethysmog-
raphy method is a relatively new technique to measure
body composition. It has shown to be an accurate system in
comparison with more conventional methods of body
composition measurement like hydrostatic weighing and
dual energy X-ray absorptiometry (DEXA) (Fields et al
2002). Moreover, non-invasive evaluation of body compo-
sition in this manner is fast and safe, not only in adults but
also especially in children above 6 years of age (Fields et al
2002).
In order to gain more insight into the body composition
of children with PKU, we designed a study in which the
BodPod system was used to analyse body composition in
these patients.
Patients and methods
All patients diagnosedwith PKU born between 1991 and 2001
and treated in our centre were included in this study. Patients
had been identified by newborn screening and required dietary
treatment for PHE level control. Diagnosis was confirmed by
mutation analysis of the phenylalanine hydroxylase gene.
Patients were treated from birth according to the Dutch PKU
Guidelines, with a natural protein restricted diet and supple-
mentation of PHE-free amino acids. The average protein
intake was 1.3–1.5 times above RDA. None of the children
received BH4 supplementation. Children with hyperphenyla-
laninaemia requiring only minor dietary protein restriction
without amino acid supplementation were excluded.
Body composition in patients with PKU was measured
using the BodPod whole body air-displacement plethys-
mography method (Life Measurement Incorporation©;
Fig. 1). After system warming-up, calibration and manual
entering of gender, age and body height of the children,
body weight was the first parameter to be determined by
stepping on the BodPod weighing scale (Life Measurement
Incorporation© 2004). Second, patients were seated within
the BodPod chamber wearing tight underwear and a
bathing cap, to minimize extracorporeal air volumes which
could eventually bias the measurements (Life Measurement
Incorporation© 2004). Next, body volume was measured
indirectly by determining the pressure change caused by the
volume of air displacement of the subject sitting inside the
tightly closed chamber. The thoracic gas volume was
determined by letting the child breathe through a tube
connected within the BodPod, to correct for the air volume
contained within the lungs during the measurement proce-
dure (Life Measurement Incorporation© 2004). From body
Fig. 1 A child within the BodPod whole body air-displacement
plethysmograph
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mass and volume, and through body density, total fat mass,
total fat free mass and the body fat percentage were
calculated by the BodPod system (Life Measurement
Incorporation© 2004). Total measurement time was ap-
proximately 4 minutes. Where lung volume measurements
failed to succeed, average lung volumes were predicted by
the BodPod system (Life Measurement Incorporation©
2004), and adjusted manually afterwards using specific
formulas suitable for BodPod measurements in children
(Fields et al 2004).
Each patient was matched for gender and age with one
healthy control subject, of whom BodPod analysis data were
derived from the Division of Human Nutrition at the
WageningenUniversity and Research Centre, TheNetherlands.
Blood PHE levels (in μmol/L) of patients with PKU
were determined every 1–3 months in the year preceding
BodPod measurements, using the High Pressure Liquid
Chromatography-Tandem Mass Spectrometry (HPLC-MS-
MS) analysis method based on the procedure described by
Chace et al (1993).
Statistical analysis
Subject characteristics were evaluated for accurate match-
ing by calculating ranges and means as well as standard
deviations of age, height and body weight of patients with
PKU and their healthy control counterparts. In addition, the
body mass index (BMI) was determined [weight(kg)/height
(m)2]. Median values were calculated when a parameter did
not show normal distribution. Independent samples t tests
were applied to verify whether subject characteristics
differed significantly between both groups.
Independent samples t tests were used to test whether
mean body fat percentages differed significantly between
patients with PKU and healthy controls. In addition,
because puberty changes body composition, subgroup
analysis was performed for boys and girls ≤11 years
and >11 years of age. Based on previous repeated measure-
ments in 18 healthy children in our laboratory (6–12 months
apart), a power analysis demonstrated that with 20 subjects
in each group, a 2.9% difference in body fat would be
statistically significant (confidence level α of 5%, power of
80% and a within-subject standard deviation of 3.4% body
fat). Linear regression analysis was applied to study the
association between body fat percentage and body weight
in patients with PKU as well as in healthy control subjects.
In patients with PKU, individual median values of
monthly to quarterly blood PHE levels, determined within
1 year before BodPod measurements, were calculated.
Mann–Whitney non-parametric analysis was applied to
see whether mean blood PHE levels, calculated from
individual median values, differed significantly among
PKU patient subgroups. Linear regression analysis was
performed to evaluate the correlation of blood PHE level
with body fat percentage in these children.
The medical ethics committee of the Wageningen
University and Research Centre, The Netherlands, has
postulated that the study did not require their approval
(06/17).
Results
Two out of 26 patients were excluded: one child with co-
existing type I diabetes mellitus and one patient with co-
existing severe attention deficit hyperactivity disorder. A
total number of 24 children were subsequently invited, and
both parents and children agreed to participate. In 4
children, body composition could not be measured due to
anxiety and/or agitation. Analysis results were therefore
available from 20 patients.
Both patients with PKU (n=20) and healthy controls
(n=20) consisted of 7 boys and 13 girls. Median age in
both groups was 10.0 years (Table 1). Children with PKU
were comparable to their gender- and age-matched healthy
counterparts with respect to height (144.2 ± 18.7 cm vs
150.7 ± 14.1 cm; 95% confidence interval (CI) −17.2 to
4.0 cm), body weight (41.2 ± 16.7 kg vs 40.7 ± 11.9 kg;
95% CI −8.8 to 9.8 kg) and BMI (18.8 ± 3.5 kg/m2 vs
17.5 ± 2.0 kg/m2; 95% CI –0.5 to 3.2 kg/m2) (Table 1).
The mean body fat percentage was significantly higher
in patients with PKU compared to healthy control subjects
(25.2 ± 7.3% vs 18.4 ± 5.8%; p=0.002) (Fig. 2, Table 2).
This difference was most pronounced in girls (24.8 ± 8.2%
vs 18.7 ± 4.4%; p=0.026) and especially above 11 years of
age (30.1 ± 5.5% vs 21.5 ± 2.2%; p=0.027) (Table 2).
Furthermore, body fat percentage in patients with PKU
increased with body weight (R=0.693, p=0.001) (Fig. 3).
Table 1 Subject characteristics for both patients with PKU and
healthy control subjects (n=40)




Ageb (years) Range 6–16 7–16
Median 10.0 10.0
Height (cm) Range 114.0–175.1 123.0–179.0
Mean ± SD 144.2 ± 18.7 150.7 ± 14.1
Weight (kg) Range 18.5–76.2 23.0–74.0
Mean ± SD 41.2 ± 16.7 40.7 ± 11.9
BMI (kg/m2) Range 14.0–25.3 14.2–23.1
Mean ± SD 18.8 ± 3.5 17.5 ± 2.0
a In both groups (n=20), gender was equally distributed (7 boys and 13 girls)
b Age did not show a normal distribution; therefore only range and median
are given
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In the healthy control group, this increase was not observed
(R=0.250, p=0.287) (Fig. 3).
The mean blood PHE level in patients with PKU (n=20),
calculated from monthly to quarterly median individual
values, was 375 (±253) μmol/L (Table 3). Girls (n=13)
showed on average 129 μmol/L higher mean PHE level
than boys (n = 7) (420 ± 303 μmol/L vs 291 ± 77 μmol/L;
Table 3). This difference was even more pronounced above
11 years of age [562 ± 481 μmol/L (n=4) vs
304 ± 72 μmol/L (n=3); Table 3]. Mann–Whitney non-
parametric analysis however, applied because PHE level
did not have a normal distribution, showed that these PHE
level differences between PKU patient subgroups were not
significant (data not presented). After log-transformation of
mean blood PHE level (to yield a normal distribution),
linear regression analysis failed to show a correlation of
PHE level with body fat percentage in patients with PKU
(R=0.079, p=0.740).
Discussion
Our data show that a higher body fat percentage is present
in patients with PKU compared to healthy control subjects,
especially in girls above 11 years of age. Our study
furthermore confirms that the BodPod whole body air-
Fig. 2 Boxplot of body fat percentage in patients with PKU (n=20)
compared to healthy control subjects (n=20)
Table 2 Body fat percentage in patients with PKU compared to healthy control subjects (n=40), with gender and age taken apart








All subjects (n=40) All ages 25.2 ± 7.3 18.4 ± 5.8 0.002* 2.6–11.0
Age ≤11 years (n=26) 24.1 ± 7.6 18.6 ± 6.4 0.056 −0.1 to 11.2
Age >11 years (n=14) 27.2 ± 7.0 18.2 ± 4.6 0.014* 2.1–16.0
Boys (n=14) All ages 25.9 ± 5.8 17.9 ± 8.1 0.056 −0.2 to 16.2
Age ≤11 years (n=8) 27.8 ± 4.0 21.1 ± 9.8 0.273 −8.0 to 21.4
Age >11 years (n=6) 23.4 ± 7.9 13.7 ± 2.4 0.113 −3.6 to 22.8
Girls (n=26) All ages 24.8 ± 8.2 18.7 ± 4.4 0.026* 0.8–11.5
Age ≤11 years (n=18) 22.5 ± 8.4 17.5 ± 4.7 0.135 −1.8 to 11.8
Age >11 years (n=8) 30.1 ± 5.5 21.5 ± 2.2 0.027* 1.4–15.9
*p <0.05
Fig. 3 Scatterplot with regression lines of body fat percentage against
body weight in 20 patients with PKU ( ) (R=0.693, p=0.001)*(—) and
in 20 healthy control subjects ( ) (R=0.250, p=0.287) (- - - - - -). *p<0.05
J Inherit Metab Dis (201 ) 3 (Suppl 3):S283–S2880 3    S286
displacement plethysmography method is a convenient
method to use in children with PKU.
In literature on PKU, results from weight and body
composition studies are inconsistent. Whereas McBurnie et
al (1991) reported a higher and above average weight in
patients with PKU compared to healthy control subjects,
Allen et al (1996) and Huemer et al (2007) found no
significant differences in weight and body composition
between these groups. Our data on the contrary show,
within a population of only 20 patients with PKU and 20
healthy control subjects, a significant difference in body
composition. Although BMI values are similar, a higher
body fat percentage is present in children with PKU,
especially in girls aged 11 years or older.
Since serum PHE values reflect dietary compliance
particularly in older children (McBurnie et al 1991; Walter
et al 2002), blood PHE levels in patients with PKU were
evaluated. McBurnie et al (1991) showed a positive
correlation of serum PHE values with body weight in
children with PKU, and particularly in girls. We did not
find an association between mean blood PHE level and
body fat percentage in patients with PKU. Although girls
above 11 years of age with PKU show mean PHE levels
near the target level of 600 μmol/L, standard deviations
were remarkably large due to great inter-individual varia-
tions, and PKU subgroup sizes were relatively small, both
of which explain our statistical analysis.
Singh et al (2009) show that the prevalence of
overweight in Dutch adolescents (mean age 12.7 years) is
higher in the case of non-Western origins (i.e. at least one
parent born in Latin America, Africa, Turkey or Asia)
compared to adolescents of Dutch descent. In the present
study, although the numbers are very small, this phenom-
enon should also be taken into account. A total of 4 out of
20 patients with PKU (mean age 10.2 years) are from
Turkish (3) and Latin American (1) descent, and 1 of them
belongs to the subgroup with the highest body fat
percentage (girls ≥11 years of age). The healthy control
subjects on the contrary are all of Dutch Caucasian descent.
We therefore looked into the effect of exclusion of all 4
patients with PKU and a non-Western origin, along with
their matched healthy counterparts, on body fat percentage.
This did not change our conclusions.
The present study shows, within a group of only 20
children with PKU, a higher body fat percentage, especially
in girls above 11 years of age. The BodPod whole body air-
displacement plethysmography method was found to be
very suitable in this setting. Because the underlying
aetiology of higher body fat percentages in patients with
PKU compared to healthy control subjects cannot be
clarified to date, further research is mandatory not only in
prospect of elucidating disease and/or diet related changes
in growth and body composition but also in relation to
overall disease management strategies and outcome hall-
marks. We therefore propose to regularly follow-up patients
with PKU whenever a BodPod whole body air-
displacement plethysmography method is available.
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